期刊文献+

IL-6表观遗传改变调节SOCS3在大肠癌发病机制中的作用 被引量:4

Effect of the SOCS3 expression activates IL-6/STAT3 signal pathway via Abnormal methylation alteration of IL-6 in colorectal cancer
原文传递
导出
摘要 目的检测大肠癌(CRC)中IL-6、SOCS3基因mRNA表达和启动子甲基化状态,以及STAT3基因mRNA表达水平,探讨大肠癌中IL-6、SOCS3基因表观遗传学改变及其对IL-6/STAT3通路的影响。方法实时荧光定量PCR检测20例CRC癌组织及癌旁组织IL-6、SOCS3及STAT3基因mRNA水平,甲基化特异性PCR(MSP)检测SOCS3甲基化状态,亚硫酸氢盐测序(BSP)检测IL-6启动子甲基化状态。结果与癌旁组织相比,癌组织中IL-6、STAT3 mRNA表达显著增高(P<0.05),而SOCS3显著降低,IL-6与SOCS3表达呈负相关;癌组织中IL-6启动子-633、-611、-575、-575bp位点甲基化水平均降低,而SOCS3则呈现高度甲基化状态(P<0.05)。结论大肠癌中IL-6和SOCS3基因DNA甲基化状态异常,影响基因表达,从而诱导IL-6/STAT3信号转导通路持续活化,促进了大肠癌的发生发展。 Abstract: Objective To detect the methylation status,mRNA expression of IL-6 and SOCS3 genes and the mRNA ex- pression of STAT3 gene as well in colorectal cancer (CRC). Furtherly,to explore the effect of methylation of IL-6 on SOCS3 gene expression and consequently on the IL-6/STAT3 pathway. Methods The expressions of IL-6, SOCS3, STAT3 mRNA were detected by quantitative reverse transcription polymerase chain reaction (QRT-PCR). The methylation status of SOCS3 and IL- 6 genes promoter CpG island were assayed by methylation specific PCR (MSP) and bisulfite sequencing PCR (BSP) ,respec- tively. Results The expressions of IL-6, STAT3 in CRC were significantly up-regulated, while SOCS3 expression was signifi- cantly reduced. There was a negative correlation between IL-6 and SOCS3 expression in cancer tissue; Moreover, SOCS3 was shown and the methylation levels of IL-6 start sub -633 ,-611 ,-575 ,-575bp sites were much lower in cancer tissue than those in the adjacent tissues ( P 〈 0. 05 ). Conclusion Abnormal methylation status of IL-6 and SOCS3 caused gene expression chan- ges and induced activation of the IL-6/STAT3 signaling pathway ,which may contribute to the pathogenesis of colorectal cancer.
出处 《临床消化病杂志》 2013年第6期337-341,共5页 Chinese Journal of Clinical Gastroenterology
基金 湖北省自然科学基金(2011CDB530) 国家自然科学基金面上项目(81270468)
关键词 大肠癌 IL-6 STAT3 SOCS3 DNA甲基化 Colorectal cancer IL-6/STA33 SOCS3 DNA methylation
  • 相关文献

参考文献11

  • 1NIWA Y,KANDA H,SHIKAUCHI Y,et al.Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma[J].Oncogene,2005,24 (42):6406-6417.
  • 2KNUPFER H,PREISS R.Serum interleukin-6 levels in colorectal cancer patients--a summary of published results[J].Int J Colorectal Dis,2010,25 (2):135-140.
  • 3LIN JT,WANG IY,CHEN MK,et al.Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6[J].Exp Cell Res,2013,27(3):140-145.
  • 4NEURATH MF,FINOTTO S.IL-6 signaling in autoimmunity,chronic inflammation and inflammation-associated cancer[J].Cytokine Growth Factor Rev,2011,22 (2):83-89.
  • 5CANTOR MJ.The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.Am J Gastroenterol[Z].P N.2005:5,1134-1142.
  • 6CACEV T,JOKIC M,LONCAR B,et al.Intedeukin-6-174 G/C polymorphism is not associated with IL-6 expression and susceptibility to sporadic colon cancer[Z].DNA Cell Biol.2010 Apr; 29 (4):177-82.
  • 7HE B,YOU L,UEMATSU K,et al.SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer[J].Proc Natl Acad Sci U S A,2003,100(24):14133-14138.
  • 8ISOMOTO H,MOTI J L,KOBAYASHI S,et al.Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing[J].Gastroenterology,2007,132(1):384-396.
  • 9YASUKAWA H,OHISHI M,MORI H,et al.IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages[J].Nat Immunol,2003,4(6):551-556.
  • 10LI Y,DEURING J,PEPPELENBOSCH MP,et al.IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer[J].Carcinogenesis,2012,33 (10):1889-1896.

同被引文献32

  • 1Engstrom PF, Arnoletti JP, Benson AB 3rd, et al. NCCN Clinical Practice Guidelines in Oncology:rectal cancer [ J ]. J Natl Compr Canc Netw,2009,7(8) :838 -881.
  • 2Garajov6 I, Svoboda M, Slaby O, et al. Possibilities of resist- ance prediction to neoadjuvant concomitant chemoradiother- apy in the treatment algorithm of patients with rectal carci- noma[ J]. Klin Onkol,2008,21 (6) :330 - 337.
  • 3Wang L, Zhong XG, Peng YF, et al. Prognostic value of pre- treatment level of carcinoembryonic antigen on tumour down- staging and early occurring metastasis in locally advanced rectal cancer following neoadjuvant radiotherapy (30 Gy in 10 fractions) [ J]. Colorectal Dis,2014,16 ( 1 ) :33 - 39.
  • 4Larsen SG, Wiig JN, Dueland S, et al. Prognostic factors after preoperative irradiation and surgery for locally advanced rec- tal cancer[ J]. Eur J Surg Oncol,2008,34(4) :410-417.
  • 5Gleeson FC, Clain JE, Papachristou GI, et al. Prospective as- sessment of EUS criteria for lymphadenopathy associated with rectal cancer [ J ]. Gastrointest Endosc, 2009,69 ( 4 ) : 896 - 903.
  • 6Chert VW,Hsieh MC,Charlton ME,et al. Analysis of stage and clinical/prognostic factors for colon and rectal cancer from SE- ER registries:AJCC and collaborative stage data collection sys- tem[ J]. Cancer,2014,120 ( Suppl 23 ) :3 793 - 3 806.
  • 7Saif MW,Chu E. Biology of colorectal cancer[ J]. Cancer J, 2010,16(3) :196 -201.
  • 8Yoshida K, Murata M, Yamaguchi T, et al. TGF-/Smad sig- naling during hepatic fibro-careinogenesis (review) [ J ]. Int J Oncol,2014,45(4) :1 363 -1 371.
  • 9Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer--a survey [ J ]. Biochim Biophys Acta, 2007,1 775 (1) :181 -232.
  • 10Dreesen O, Brivanlou AH. Signaling pathways in cancer and embryonic stem cells [ J ]. Stem Cell Rev, 2007,3 ( 1 ) :7 - 17.

引证文献4

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部